Molecular Pharmacology (USA), Ltd. (MLPH)

Market Cap	599.73K
Revenue (ttm)	n/a
Net Income (ttm)	-105.18K
Shares Out	999.55M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Average Volume	119,162
Open	0.0006
Previous Close	n/a
Day's Range	0.0006 - 0.0006
52-Week Range	0.0000 - 0.0010
Beta	-4.38
RSI	49.57
Earnings Date	n/a

About MLPH

Molecular Pharmacology (USA) Limited, a development stage company, develops and commercializes pain and inflammation management products primarily in Australia and the United States. The company, through its subsidiary, Molecular Pharmacology Pty. Ltd., develops analgesic and anti-inflammatory molecule, known as Tripeptofen for the treatment of common every-day pain. Its products are available in various dosage forms, formulations, line extensions, and package configurations. The company focuses on marketing its products through pharmaceutical ...

• Industry: Shell Companies
• Sector: Financials
• CEO: Jeffrey Edwards
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: MLPH